VA
MDNA

VR Adviser’s Medicenna Therapeutics Corp. Common Shares MDNA Stock Holding History

VR Adviser’s Portfolio MDNA Stock Details MDNA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q4 		– Sell
-92,453
Closed -$383K – 28
2020
Q3 		$383K Buy
+92,453
New +$372K 0.07% 22

Other funds holding MDNA

AIC
AWM Investment Company New York $903M AUM 163.47% 1-Year Est. Return
Verition Fund Management
Verition Fund Management Greenwich, Connecticut $15.4B AUM 30.69% 1-Year Est. Return
SCM
Soleus Capital Management Greenwich, Connecticut $2.47B AUM 115.63% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
SCM
Silverarc Capital Management Boston, Massachusetts $980M AUM 470.8% 1-Year Est. Return
TAM
Tocqueville Asset Management New York $6.74B AUM 32.29% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $303B AUM 30.15% 1-Year Est. Return
RG
Rathbones Group Liverpool, United Kingdom $27.1B AUM 20.2% 1-Year Est. Return
Creative Planning
Creative Planning Overland Park, Kansas $147B AUM 18.73% 1-Year Est. Return
MCWS
McKinley Carter Wealth Services Wheeling, West Virginia $1.94B AUM 20.7% 1-Year Est. Return

VR Adviser's MDNA Position: Q4 2020 in Review

VR Adviser sold out of Medicenna Therapeutics Corp. Common Shares (MDNA) in Q4 2020, closing a stake of 92,453 shares — an estimated $383K sold.

VR Adviser first reported a position in MDNA in Q3 2020 and held it in 1 quarter. The position peaked at $383K in Q3 2020. 21 funds tracked by Wall St. Rank hold MDNA as of Q4 2020.

  • VR Adviser reported no remaining Medicenna Therapeutics Corp. Common Shares position as of Q4 2020 after selling out during the quarter.
  • VR Adviser sold 92,453 Medicenna Therapeutics Corp. Common Shares shares in Q4 2020, an estimated $383K.
  • VR Adviser first reported a position in Medicenna Therapeutics Corp. Common Shares in Q3 2020 and held it in 1 quarter.
  • VR Adviser's Medicenna Therapeutics Corp. Common Shares position peaked at $383K in Q3 2020.
  • 21 funds tracked by Wall St. Rank held Medicenna Therapeutics Corp. Common Shares as of Q4 2020.

Based on VR Adviser's 13F filing for Q4 2020, filed 12 Feb 2021.